君实生物：董事长熊俊拟增持公司A股和H股股份 合计增持金额不低于人民币1亿元

Core Viewpoint - The chairman of Junshi Biosciences, Xiong Jun, plans to increase his holdings in the company's A-shares and H-shares, with a total investment of no less than RMB 100 million [1] Group 1: Shareholding Plan - Xiong Jun intends to increase his holdings starting from April 12, 2025, over a period of 12 months [1] - The total amount for the share purchase will be no less than RMB 100 million, with at least RMB 50 million allocated for A-shares [1] - The acquisition will be conducted through the Shanghai Stock Exchange and the Hong Kong Stock Exchange, utilizing methods such as centralized bidding and block trading [1]